-
Understanding the role of type I IFN in cutaneous lupus and dermatomyositis: towards better therapeutics Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-09-12 Grace A. Hile, Victoria P Werth
-
Enhancing intracellular cholesterol efflux in chondrocytes alleviates osteoarthritis progression Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-09-12 Gyuseok Lee, Jiye Yang, Su‐Jin Kim, Thanh‐Tam Tran, Sun Young Lee, Ka Hyon Park, Seung‐Hee Kwon, Ki‐Ho Chung, Jeong‐Tae Koh, Yun Hyun Huh, Jong‐Keun Seon, Hyun Ah Kim, Jang‐Soo Chun, Je‐Hwang Ryu
ObjectivesOsteoarthritis (OA) is the most common degenerative disease worldwide with no practical means of prevention and limited treatment options. Recently, our group unveiled a novel mechanism contributing to OA pathogenesis in association with abnormal cholesterol metabolism in chondrocytes. In this study, we aimed to establish a clinical link between lipid profiles and OA in humans, assess the
-
Emapalumab Use in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: the REAL-HLH Study Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-09-08 Shanmuganathan Chandrakasan, Carl E. Allen, Deepika Bhatla, John Carter, May Chien, Robert Cooper, Lauren Draper, Olive S. Eckstein, Rabi Hanna, J. Allyson Hays, Michelle L. Hermiston, Ashley P. Hinson, Patricia M. Hobday, Michael S. Isakoff, Michael B. Jordan, Jennifer W. Leiding, Renee Modica, Taizo A. Nakano, Abiola Oladapo, Sachit A. Patel, Priti Pednekar, Mona Riskalla, Susmita N. Sarangi, Prakash
Rheumatologic disease–associated hemophagocytic lymphohistiocytosis (HLH), a rare, life-threatening, systemic hyperinflammatory syndrome, occurs as a complication of underlying rheumatologic disease. Real-world evidence is lacking on emapalumab, a fully human monoclonal antibody that neutralizes the proinflammatory cytokine interferon-gamma, approved for treating patients with primary HLH.
-
Erratum Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-09-10
Ong, M.S., Ringold, S., Kimura, Y., Schanberg, L.E., Tomlinson, G.A., Natter, M.D. and the CARRA Registry Investigators. Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study. Arthritis Rheumatol, 73: 1910–1920. https://doi.org/10
-
Do Existing MRI Definitions of Knee Osteoarthritis Identify Knees That Will Develop Clinically Significant Disease Over Up To 11 Years of Follow‐Up? Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-09-04 Alison H. Chang, Frank W. Roemer, Ali Guermazi, Orit Almagor, Jungwha (Julia) Lee, Joan S. Chmiel, Lutfiyya N. Muhammad, Jing Song, Leena Sharma
ObjectivesIn individuals without radiographic knee osteoarthritis (KOA), we investigated whether MRI‐defined KOA at baseline was associated with incident radiographic and symptomatic disease during up to 11 years of follow‐up.MethodsOsteoarthritis Initiative participants without tibiofemoral radiographic KOA at baseline were assessed for MRI‐based tibiofemoral cartilage damage, osteophyte presence
-
Diversity and epitope spreading of anti‐RNA polymerase III antibodies in systemic sclerosis: a potential biomarker for skin and lung involvement Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-09-02 Hirohito Kotani, Kazuki M. Matsuda, Kei Yamaguchi, Chihiro Ono, Emi Kogo, Koji Ogawa, Yuki Kobayashi, Teruyoshi Hisamoto, Ruriko Kawanabe, Ai Kuzumi, Takemichi Fukasawa, Asako Yoshizaki‐Ogawa, Naoki Goshima, Shinichi Sato, Ayumi Yoshizaki
ObjectiveEpitope spreading (ES), involving autoantibodies, plays a crucial role in the development and persistence of autoimmune reactions in various autoimmune diseases. This study aimed to investigate the relationship between ES of anti‐RNA polymerase III (RNAP III) antibodies (ARAs) and the clinical manifestations of systemic sclerosis (SSc).MethodsWe investigated whether intermolecular ES occurs
-
Reply to: Refining Research on Systemic Lupus Erythematosus with Key Considerations Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-27 Meiqi Xing, Yudiyang Ma, Feipeng Cui, Dankang Li, Jianing Wang, Linxi Tang, Lei Zheng, Jian Yang, Yaohua Tian
-
-
Refining Research on Systemic Lupus Erythematosus with Key Considerations Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-27 Qing Zhou
-
-
Relapse prediction in ANCA‐associated vasculitis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-27 Eithne Nic an Ríogh, Mark A. Little
-
Mutual amplification of GLI2/Hedgehog and cJUN/AP1 signaling in fibroblasts in Systemic Sclerosis (SSc) – potential implications for combined therapies Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-27 Christina Bergmann, Sara Chenguiti Fakhouri, Trinh‐Minh Thuong, Tim Filla, Aleix Rius Rigau, Arif B. Ekici, Benita Merlevede, Ludwig Hallenberger, Honglin Zhu, Clara Dees, Alexandru‐Emil Matei, Janina Auth, Andrea‐Hermina Györfi, Xiang Zhou, Simon Rauber, Aline Bozec, Nicholas Dickel, Chunguang Liang, Meik Kunz, Georg Schett, Jörg H.W. Distler
ObjectivesDeregulation of the cJUN/AP1‐ and hedgehog/GLI2 signaling pathways have been implicated in fibroblast activation in Systemic Sclerosis (SSc). However, the consequences of their concomitant upregulation are unknown. Here, we tested the hypothesis that mutual amplification of both pathways might drive persistent fibroblast activation.MethodsCultured fibroblasts and skin sections of diffuse
-
Clinical Images: A large disfiguring nasal mass and progressive dyspnea Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-27 Renato Ferrandiz‐Espadin, Sonal Choudhary, Didem Saygin
-
-
-
Targeting CD13/aminopeptidase N as a novel therapeutic approach for scleroderma fibrosis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-23 Sei Muraoka, William D. Brodie, Megan N. Mattichak, Mikel Gurrea‐Rubio, Yuzo Ikari, Caroline Foster, M. Asif Amin, Neha Khanna, Hafsa Amin, Phillip L. Campbell, Sirapa Vichaikul, Ellen N. Model, Morgan M. Omara, Steven Petrovski, Karly Kozicki, Camilia Amarista, Anna Webber, Mustafa Ali, Pamela J. Palisoc, Jonatan Hervoso, Jeffrey H. Ruth, Lam C. Tsoi, John Varga, Johann E. Gudjonsson, Dinesh Khanna
-
The relationship between ultrasound and physical examination in the assessment of enthesitis in SpA patients: results from the DEUS multicentre study Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-22 Andrea Di Matteo, Stefano Di Donato, Gianluca Smerilli, Andrea Becciolini, Federica Camarda, Alberto Cauli, Tomás Cazenave, Edoardo Cipolletta, Davide Corradini, Juan Jose de Agustin, Giulia M Destro Castaniti, Eleonora Di Donato, Emine Duran, Bayram Farisogullari, Marco Fornaro, Francesca Francioso, Pamela Giorgis, Raquel Granados, Amelia Granel, Cristina Hernandez Diaz, Rudolf Horvath, Jana Hurnakova
-
Clinical Images: Painless subcutaneous swellings in a middle-aged man. Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-20 Alekhya Amudalapalli,Rasmi Ranjan Sahoo,Ashlesha Shukla,Pradeepta Sekhar Patro
-
Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-20 Shinji Izuka, Natsuka Umezawa, Toshihiko Komai, Yusuke Sugimori, Naoki Kimura, Fumitaka Mizoguchi, Yuichiro Fujieda, Keita Ninagawa, Takeshi Iwasaki, Katsuya Suzuki, Tsutomu Takeuchi, Koichiro Ohmura, Tsuneyo Mimori, Tatsuya Atsumi, Eiryo Kawakami, Akari Suzuki, Yuta Kochi, Kazuhiko Yamamoto, Shinsuke Yasuda, Tomohisa Okamura, Mineto Ota, Keishi Fujio
-
Enhanced Type 1 Interferon Signature in Axial Spondyloarthritis Patients Unresponsive to Secukinumab Treatment Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-19 Addison Pacheco, Sinead Maguire, Zoya Qaiyum, Michael Tang, Adam Bridger, Melissa Lim, Fataneh Tavasolian, Enoch Yau, Sarah Q Crome, Nigil Haroon, Robert D Inman
-
Efficacy versus effectiveness: The HORIZON Pivotal Fracture Trial and its emulation in Claims Data Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-12 Elvira D'Andrea, Sebastian Schneeweiss, Jessica M. Franklin, Seoyoung C. Kim, Robert J. Glynn, Su Been Lee, Shirley V. Wang
ObjectivesTo evaluate the concordance of results between the HORIZON‐Pivotal Fracture Trial (PFT) and a non‐randomized database study designed to emulate the trial.MethodsHORIZON‐PFT evaluated the efficacy of zoledronic acid vs placebo in reducing the risk of hip fractures and found a 41% risk reduction over a 3‐year treatment period (HR = 0.59; 95% CI 0.42 to 0.83). Using two U.S. claims databases
-
Novel Genetic Loci in Early-Onset Gout Derived From Whole-Genome Sequencing of an Adolescent Gout Cohort Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-08 Aichang Ji, Yang Sui, Xiaomei Xue, Xiapeng Ji, Wenrui Shi, Yongyong Shi, Robert Terkeltaub, Nicola Dalbeth, Riku Takei, Fei Yan, Mingshu Sun, Maichao Li, Jie Lu, Lingling Cui, Zhen Liu, Can Wang, Xinde Li, Lin Han, Zhanjie Fang, Wenyan Sun, Yue Liang, Yuwei He, Guangmin Zheng, Xuefeng Wang, Jiayi Wang, Hui Zhang, Lei Pang, Han Qi, Yushuang Li, Zan Cheng, Zhiqiang Li, Jingfa Xiao, Changqing Zeng, Tony
Mechanisms underlying the adolescent-onset and early-onset gout are unclear. This study aimed to discover variants associated with early-onset gout.
-
Toll-Like Receptor 8 is Expressed in Monocytes in Contrast to Plasmacytoid Dendritic Cells and Mediates Aberrant Interleukin-10 Responses in Patients With Systemic Sclerosis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-07 Christine Ehlers, Thea Thiele, Hannah Biermann, Stephan Traidl, Luzia Bruns, Annett Ziegler, Matthias Schefzyk, Lea M. Bartsch, Ulrich Kalinke, Torsten Witte, Theresa Graalmann
-
Features of Axial Spondyloarthritis in Two Multicenter Cohorts of Patients with Psoriasis, Uveitis, and Colitis Presenting with Undiagnosed Back Pain Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-06 Walter P. Maksymowych, Raj Carmona, Ulrich Weber, Sibel Zehra Aydin, James Yeung, Jodie Reis, Ariel Masetto, Sherry Rohekar, Dianne Mosher, Olga Zouzina, Liam Martin, Stephanie O. Keeling, Joel Paschke, Rana Dadashova, Amanda Carapellucci, Stephanie Wichuk, Robert G. Lambert, Jonathan Chan
We aimed to assess the following: (1) the frequency of axial spondyloarthritis (axSpA) according to extra-articular presentation and HLA-B27 status, (2) clinical and imaging features that distinguish axSpA from non-axSpA, and (3) the impact of magnetic resonance imaging (MRI) on diagnosis and classification of axSpA.
-
Long‐term follow‐up of anti‐infliximab antibodies in radiographic axial spondyloarthritis patients: a marker of drug survival and tapering: comment on the article by Clarissa et al Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-02 Jin Xian Huang, Guo‐Wen Zhang
-
Reply letter Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-02 Carla G. S. Saad, Ana Cristina Medeiros‐Ribeiro, Clarissa Q. Pimentel, Eloisa Bonfa
-
Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-08-01 Tristan Pascart, Augustin Latourte, Sara K. Tedeschi, Nicola Dalbeth, Tuhina Neogi, Antonella Adinolfi, Uri Arad, Mariano Andres, Fabio Becce, Thomas Bardin, Edoardo Cipolletta, Hang-Korng Ea, Georgios Filippou, Emilio Filippucci, John FitzGerald, Annamaria Iagnocco, Tim L. Jansen, Matthijs Janssen, Frédéric Lioté, Alexander So, Geraldine M. McCarthy, Roberta Ramonda, Pascal Richette, Ann Rosenthal
The study objective was to examine the disease, demographic, and imaging features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (CPPD) disease, ie, recurrent acute calcium pyrophosphate (CPP) crystal arthritis, chronic CPP crystal inflammatory arthritis, and crowned dens syndrome (CDS).
-
Diversity and Inclusivity in Rheumatology Publications Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-31 Amr H. Sawalha, Kelli D. Allen, Candace H. Feldman, S. Sam Lim, Andras Perl, Daniel H. Solomon, Edith M. Williams
-
-
-
Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022 Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-30 Eric T. Roberts, Jing Li, Nick Bansback, Chien-Wen Tseng, Steve Shiboski, Gabriela Schmajuk, Jinoos Yazdany
Biosimilars have the potential to reduce spending on biologic drugs, yet uptake has been slower than anticipated. We investigated how successive introductions of infliximab biosimilars influenced their adoption by major US insurance providers.
-
-
-
The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-28 Rebecca T. Brooks, Brent Luedders, Austin Wheeler, Tate M. Johnson, Yangyuna Yang, Punyasha Roul, Apar Kishor Ganti, Namrata Singh, Brian C. Sauer, Grant W. Cannon, Joshua F. Baker, Ted R. Mikuls, Bryant R. England
We aimed to evaluate lung cancer risk in patients with rheumatoid arthritis (RA) and RA-interstitial lung disease (ILD).
-
CD4+CD8αlow T Cell Clonal Expansion Dependent on Costimulation in Patients With Rheumatoid Arthritis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-25 Felix Beck, Phuong Nguyen, Anne Hoffmann, Lucie Loyal, Andreas Thiel, Marc Melzer, Hannah Apel, Matthias Pierer, Marco Krasselt, Olga Seifert, Anne-Marie Glimm, Tobias Hagemann, Kathrin Rothe, Ulf Wagner
-
Molecular Determinants of Neutrophil Extracellular Vesicles That Drive Cartilage Regeneration in Inflammatory Arthritis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-23 Bethan L. Thomas, Trinidad Montero-Melendez, Silvia Oggero, Magdalena K. Kaneva, David Chambers, Andreia L. Pinto, Alessandra Nerviani, Davide Lucchesi, Shani Austin-Williams, Mohammed T. Hussain, Costantino Pitzalis, Benjamin Allen, Marzia Malcangio, Francesco Dell'Accio, Lucy V. Norling, Mauro Perretti
-
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-22 Pamela F. Weiss, Timothy G. Brandon, Amita Aggarwal, Ruben Burgos-Vargas, Robert A. Colbert, Gerd Horneff, Ronald M. Laxer, Kirsten Minden, Angelo Ravelli, Nicolino Ruperto, Judith A. Smith, Matthew L. Stoll, Shirley M. Tse, Filip Van den Bosch, Walter P. Maksymowych, Robert G. Lambert, David M. Biko, Nancy A. Chauvin, Michael L. Francavilla, Jacob L. Jaremko, Nele Herregods, Ozgur Kasapcopur, Mehmet
-
Mitochondrial Control of Proteasomal Psmb5 Drives the Differentiation of Tissue-Resident Memory T Cells in Patients with Rheumatoid Arthritis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-22 Tong Wu, Danhua Su, Lei Zhang, Ting Liu, Qianliang Wang, Chenchu Yan, Mengdi Liu, Huiyan Ji, Jiaxin Lei, Ming Zheng, Zhenke Wen
To explore T cell-intrinsic mechanisms underpinning the mal-differentiation of tissue-resident memory T (Trm) cells in patients with rheumatoid arthritis (RA).
-
Performance of the 2023 American College of Rheumatology/EULAR Classification Criteria for Antiphospholipid Syndrome in a Mexican Cohort Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-19 Erik Cimé-Aké, Gabriela Hernández-Molina, Amaya Llorente-Chávez, Eduardo Martín-Nares
-
Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of Osteoarthritis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-19 Christina Stevens, Samantha Norris, Liubov Arbeeva, Scott Carter, Masataka Enomoto, Amanda E. Nelson, B. Duncan X. Lascelles
The purpose of this study was to enhance the current knowledge of the relationship between the gut microbiome and osteoarthritis (OA) and associated pain using pet dogs as a clinically relevant translational model.
-
Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-19 Melissa Tordoff, Samantha L. Smith, Saskia Lawson-Tovey, Andrew D. Dick, Michael W. Beresford, Athimalaipet V. Ramanan, Kimme L. Hyrich, Andrew P. Morris, Stephen Eyre, Lucy R. Wedderburn, John Bowes
Juvenile idiopathic arthritis (JIA)–associated uveitis (JIAU) is a serious JIA comorbidity that can result in vision impairment. This study aimed to identify genetic risk factors within the major histocompatibility complex for JIAU and evaluate their contribution for improving risk classification when combined with clinical risk factors.
-
Skeletal Muscle Composition, Power, and Mitochondrial Energetics in Older Men and Women With Knee Osteoarthritis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-17 Giovanna Distefano, Stephanie Harrison, John Lynch, Thomas M. Link, Philip A. Kramer, Sofhia V. Ramos, Theresa Mau, Paul M. Coen, Lauren M. Sparks, Bret H. Goodpaster, Peggy M. Cawthon, Jane A. Cauley, Nancy E. Lane
Our objective was to investigate the overall and sex-specific relationships between the presence and severity of knee osteoarthritis (KOA) and muscle composition, power, and energetics in older adults.
-
Critical Review and Recommendations for Enhancing the Analysis of Climate Change Impacts on Rheumatic Conditions Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-10 Xiaozhen Zhao, James Cheng‐Chung Wei, Caifeng Li
-
Air Pollution, Genetic Susceptibility, and Risk of Incident Systemic Lupus Erythematosus: A Prospective Cohort Study Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-10 Meiqi Xing, Yudiyang Ma, Feipeng Cui, Dankang Li, Jianing Wang, Linxi Tang, Lei Zheng, Jian Yang, Yaohua Tian
ObjectiveThere are few existing studies that investigate the risk of systemic lupus erythematosus (SLE) associated with long‐term exposure to air pollutants. This study aimed to explore associations between long‐term exposure to air pollutants and incident SLE and further evaluate interactions and joint effects of genetic risk and air pollutants.MethodsA total of 459,815 participants were included
-
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-08 Desiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, Guillermo Pons-Estel, , Guillermo Reales, Yu Zuo, Gerard Espinosa, Timothy Radstake, Lucas L. van den Hoogen, Chris Wallace, Joel Guthridge, Judith A James, Ricard Cervera, Pier Luigi Meroni, Javier Martin, Jason S. Knight, Marta E. Alarcón-Riquelme, Amr H. Sawalha
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-08 Sindhu R. Johnson, Elana J. Bernstein, Marcy B. Bolster, Jonathan H. Chung, Sonye K. Danoff, Michael D. George, Dinesh Khanna, Gordon Guyatt, Reza D. Mirza, Rohit Aggarwal, Aberdeen Allen, Shervin Assassi, Lenore Buckley, Hassan A. Chami, Douglas S. Corwin, Paul F. Dellaripa, Robyn T. Domsic, Tracy J. Doyle, Catherine Marie Falardeau, Tracy M. Frech, Fiona K. Gibbons, Monique Hinchcliff, Cheilonda
We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs).
-
Substantive Similarities Between Synovial Fluid and Synovial Tissue T cells in Inflammatory Arthritis Via Single-Cell RNA and T cell Receptor Sequencing Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-08 Lucy E. Durham, Frances C. Humby, Nora Ng, Sarah Ryan, Rosamond Nuamah, Kathy Fung, Athul Menon Kallayil, Pawan Dhami, Bruce W. Kirkham, Leonie S. Taams
-
Weighing the Cardiovascular Risks of Low‐Dose Glucocorticoids in Rheumatoid Arthritis from Real‐World Data Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-08 Tate M. Johnson
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-08 Sindhu R. Johnson, Elana J. Bernstein, Marcy B. Bolster, Jonathan H. Chung, Sonye K. Danoff, Michael D. George, Dinesh Khanna, Gordon Guyatt, Reza D. Mirza, Rohit Aggarwal, Aberdeen Allen, Shervin Assassi, Lenore Buckley, Hassan A. Chami, Douglas S. Corwin, Paul F. Dellaripa, Robyn T. Domsic, Tracy J. Doyle, Catherine Marie Falardeau, Tracy M. Frech, Fiona K. Gibbons, Monique Hinchcliff, Cheilonda
We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies, mixed connective tissue disease, and Sjögren disease.
-
Mapping and Analysis of Protein and Gene Profile Identification of the Important Role of Transforming Growth Factor Beta in Synovial Invasion in Patients With Pigmented Villonodular Synovitis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-08 Tao Li, Yan Xiong, Jian Li, Xin Tang, Yutong Zhong, Zhigang Tang, Qiuping Zhang, Yubin Luo
Pigmented villonodular synovitis (PVNS) is a rare benign proliferative disease affecting the soft-tissue lining the synovial joints and tendons. Its etiology is poorly understood, largely limiting the availability of current therapeutic options. Here, we mapped the synovial gene and protein profiles of patients with PVNS, revealed a link between synovial inflammation and invasion, and elucidated the
-
Genetically Proxied Interleukin-13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-08 Sizheng Steven Zhao, Kimme Hyrich, Zenas Yiu, Anne Barton, John Bowes
-
-
Curating Genetic Associations With Rheumatologic Autoimmune Diseases to Improve Patient Outcomes. Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-04 S Louis Bridges,Rachel Shapira,Ivona Aksentijevich,Steven J Mack,Tony R Merriman,Clarissa J Klein,B Monica Bowen,Teri E Klein,
-
Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-04 Zhaohui Yang, Panfeng Tao, Xu Han, Anna Kozlova, Tingyan He, Egor Volchkov, Zoya Nesterenko, Dmitryi Pershin, Elena Raykina, Timur Fatkhudinov, Anastasia Korobeynikova, Ivona Aksentijevich, Jun Yang, Anna Shcherbina, Qing Zhou, Xiaomin Yu
Autoinflammation and phospholipase C (PLC) γ2–associated antibody deficiency and immune dysregulation (APLAID) syndrome is an autoinflammatory disease caused by gain-of-function variants in PLCG2. This study investigates the pathogenic mechanism of a novel variant of PLCG2 in a patient with APLAID syndrome.
-
ERG Regulates Lymphatic Vessel Specification Genes and Its Deficiency Impairs Wound Healing-Associated Lymphangiogenesis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-04 Takashi Yamashita, Ulas Kaplan, Adri Chakraborty, Grace Marden, Sami Gritli, Daniel Roh, Andreea Bujor, Marcin Trojanowski, Giovanni Ligresti, Jeffrey L. Browning, Maria Trojanowska
-
Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-04 Daniel Small
-
Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-04 Andrea Fava, Catriona A. Wagner, Carla J. Guthridge, Joseph Kheir, Susan Macwana, Wade DeJager, Tim Gross, Peter Izmirly, H. Michael Belmont, Betty Diamond, Anne Davidson, Paul J. Utz, Michael H Weisman, Laurence S. Magder, , Joel M. Guthridge, Michelle Petri, Jill Buyon, Judith A. James
-
Another Notch in the Belt of Rheumatoid Arthritis Arthritis Rheumatol. (IF 11.4) Pub Date : 2024-07-04 Stephanie R. Zack, Osama Alzoubi, Neha Satoeya, Kunwar P. Singh, Sania Deen, Wes Nijim, Myles J. Lewis, Costantino Pitzalis, Nadera Sweiss, Lionel B. Ivashkiv, Shiva Shahrara
-
-